I'm not short on this, I'm only playing the long side. I was in at $2.20 over a month ago. I watched it go over three then back down. I was kicking myself for not taking profits so sold at intervals on the next run up. I could've more than doubled my money, but played it safe. The numbers sat near $3 too long for my attention span and I plopped it in a different stock. I'm hoping to get back in before the end of the week. Long side only, sidelining the drops.
Just an observation, every time I've seen a reverse split on the otc the share price tanks and is in no way proportional to the split ratio. This is the first time I've seen one maintain fair value within days after the split. Is this because it's NASDAQ or because it's Aeolus company?
If you check SEC filings you'll see the quarterly financials are being filed late, due in the next couple days. The sudden price increase is speculative, a bet on positive earnings due to all the claims being made that Chanticleer will be profitable this year. The speculation is a quarter early. There are struggles with the current auditor and all the acquisitions. Once the kinks are worked out with financials (maybe hire a new accounting firm) this will rise to its rightful valuation. One more pullback, one more chance to accumulate IMO.
If price is dropping below $4, then why would anyone in their right mind buy up the offering at $4 with warrants at $5.50? If no one will buy the offering, there will be no dilution. If there's no dilution, then why are people selling in worry of dilution? Seems like a long opportunity from where I sit. Just wait for a good entry.
Testing was not terminated due to leakage and Takeda is being cheap!
"On May 12, 2015, Takeda initiated a formal dispute process pursuant to the terms of the Agreement claiming that Orexigen materially breached the terms of the Agreement. Takeda is seeking, among other things, that Orexigen be responsible to pay the entire cost of the new CV outcomes trial. Pursuant to the terms of the Agreement, Takeda and Orexigen will now enter into a dispute resolution process, which may include arbitration, unless the dispute can be resolved otherwise. Orexigen does not believe this dispute should impact the commercialization of Contrave.
Orexigen is currently evaluating the assertions made by Takeda and believes they are without merit. Orexigen intends to vigorously defend itself and to assert any remedies and counterclaims that it may have against Takeda."
Our Board of Directors has previously approved the repurchase of $130.0 million of FXCM Inc.'s Class A common stock (the “Stock Repurchase Program”). We are not obligated to purchase any shares under the Stock Repurchase Program which does not have an expiration date.
As of March 31, 2015, we have repurchased 5.1 million shares for $64.2 million under these authorizations.
Seems to me more like you are an ambulance chaser trying to entrap some soul unaware of the legal terminology of your state or at the federal level. At some point, what you are doing will cross the line and be entirely unethical. You or the person you take advice from will become liable and be disbarred. Cease and decist your actions along these lines. Coercing another person on a message board to cover your losses is that unethical thing I'm writing about.
Wayne's World reference? We're not worthy, we're not worthy! But it's more like talking to a McKenzie Bro on his way to a brewery tour, "What did you say? I'm too focused to hear you bro, headed to the brewery for some free samples eh."
I check here to gauge sentiment. I do my own DD and pay more attention to SEC filings and other catalysts. My opinion is, LPCN has at least one market replacement product in development. Can we just agree to disagree?
Has the FDA disclosed how many people get stomache aches from taking vitamin E, fish oil, or any lipid based supplements? Humans have been consuming fats for thousands of years! That's part of why an oral lipid based delivery system is so great.
You'll need to explain your comparison. I just don't see how you can compare a company with poor results and not enough cash to one with stellar results and plenty of cash. You also compare ALXA to a 2 penny #$%$ stock on the ALXA board. What gives?
Sentiment: Strong Buy
So you are no longer with Kristie. Your insider knowledge is gone. Check the SEC filings. A prospectus is filed and they are seeking approval for a $500 million dilution at the end of the month. That is why people are shorting this stock. That is why stock price will tank to $2.